Combining multiplexed assays of variant effect for enhanced BRCA2 variant classification.

Area of Science:

• Genetics
• Genomic Medicine
• Bioinformatics

Background:

• Accurate classification of BRCA2 variants of uncertain significance is crucial for patient risk assessment and management.
• Previous studies utilized saturation genome editing to assess variant effects, but data integration challenges remained.

Purpose of the Study:

• To develop and evaluate an improved model for classifying BRCA2 variants of uncertain significance.
• To enhance the accuracy of functional data for variant classification using ACMG/AMP guidelines.

Main Methods:

• Combined raw functional data from two saturation genome editing studies on BRCA2 variants.
• Developed four composite models, including an "Integrated VarCall Model", to analyze 6383 variants.
• Evaluated model performance using variants with established clinical classifications.

Main Results:

• The "Integrated VarCall Model" achieved 98.8% accuracy in classifying BRCA2 variants.
• This integrated model outperformed the original individual studies and other combined data approaches.
• Classified 5926 BRCA2 variants as pathogenic (735) or benign (5191) when combined with other evidence.

Conclusions:

• The "Integrated VarCall Model" provides a highly accurate method for functional variant assessment.
• This approach significantly enhances the classification of BRCA2 variants, supporting clinical decision-making.
• The findings offer valuable insights for genetic counseling and personalized risk management in individuals with BRCA2 variants.